BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1448914)

  • 21. Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat.
    Greenberg ME; Mathews MB
    Nucleic Acids Res; 1997 Dec; 25(24):5017-24. PubMed ID: 9396810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cis-acting elements in the U3 region of a simian immunodeficiency virus.
    Renjifo B; Speck NA; Winandy S; Hopkins N; Li Y
    J Virol; 1990 Jun; 64(6):3130-4. PubMed ID: 2335831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements.
    Arya SK; Gallo RC
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9753-7. PubMed ID: 2849115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New human gene encoding a positive modulator of HIV Tat-mediated transactivation.
    Shibuya H; Irie K; Ninomiya-Tsuji J; Goebl M; Taniguchi T; Matsumoto K
    Nature; 1992 Jun; 357(6380):700-2. PubMed ID: 1377363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity.
    Schwartz O; Virelizier JL; Montagnier L; Hazan U
    Gene; 1990 Apr; 88(2):197-205. PubMed ID: 2189784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of sequences in the long terminal repeat of the lymphoproliferative disease virus required for efficient transcription.
    Sarid R; Gazit A; Tronick SR; Yaniv A
    Virology; 1995 Apr; 208(2):789-94. PubMed ID: 7747452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system.
    Chowdhury M; Kundu M; Khalili K
    Oncogene; 1993 Apr; 8(4):887-92. PubMed ID: 8384357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transactivation of the two promoters of SFV-3 by different mechanisms.
    Renne R; Fleps U; Luciw PA; Neumann-Haefelin D
    Virology; 1996 Jul; 221(2):362-7. PubMed ID: 8661448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of transactivation-response sequences in the long terminal repeat of bovine immunodeficiency-like virus.
    Carpenter S; Nadin-Davis SA; Wannemuehler Y; Roth JA
    J Virol; 1993 Jul; 67(7):4399-403. PubMed ID: 8389937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.
    Seeler JS; Muchardt C; Podar M; Gaynor RB
    Virology; 1993 Oct; 196(2):442-50. PubMed ID: 8372429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques.
    Anderson MG; Hauer D; Sharma DP; Joag SV; Narayan O; Zink MC; Clements JE
    Virology; 1993 Aug; 195(2):616-26. PubMed ID: 8337835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus.
    Kim YS
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1152-9. PubMed ID: 8093034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
    J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
    Thompson FJ; Elder J; Neil JC
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():545-54. PubMed ID: 8126451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The replication activation potential of selected RNA polymerase II promoter elements at the simian virus 40 origin.
    Hoang AT; Wang W; Gralla JD
    Mol Cell Biol; 1992 Jul; 12(7):3087-93. PubMed ID: 1320196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity.
    Hiebenthal-Millow K; Pöhlmann S; Münch J; Kirchhoff F
    Virology; 2004 Jul; 324(2):501-9. PubMed ID: 15207635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.